B cell depletion for autoimmune diseases in paediatric patients

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

Stephen L. Hauser, Emmanuelle Waubant, Douglas L. Arnold et al. · New England Journal of Medicine · 2008 · 2.4K citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15

Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

Joan T. Merrill, C. Michael Neuwelt, Daniel J. Wallace et al. · Arthritis & Rheumatism · 2009 · 1.4K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +13

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial

Paul Emery, Roy Fleischmann, Anna Filipowicz‐Sosnowska et al. · Arthritis & Rheumatism · 2006 · 1.1K citations

Medicine, Internal Medicine, Pharmacotherapy +13

Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: An open‐label extension analysis

Edward Keystone, Roy Fleischmann, Paul Emery et al. · Arthritis & Rheumatism · 2007 · 334 citations

Medicine, Internal Medicine, Pharmacotherapy +15

Treatment of IgM antibody associated polyneuropathies using rituximab

Alan Pestronk · Journal of Neurology Neurosurgery & Psychiatry · 2003 · 281 citations · Full text

Life Sciences, Immunology, Neurology +12